益生菌与益生原　

益生菌与益生原　 Lactophar 益生菌与益生原 Ref. 22/10/2003 活性成份 学 名 英文名 利用的部位用 量 干酪乳杆菌 Lactobacillus casei 25 mg 2.5 miljard CFU 25亿CFU(集落形成单位) 嗜酸乳杆菌 acidophillus 25 mg Lactobacillus 2.5 miljard CFU 25亿CFU 鼠李糖乳杆菌 Lactobacillus rhamnosus 25 mg 2.5 miljard CFU 25亿CFU 德氏乳杆菌 Lactobacillus delbrueckii 25 mg 2.5 miljard CFU 25亿CFU Raftilin Raftilin 360 mg (菊糖的衍生物) Raftilose 150 mg Raftilose (菊粉中提取的低聚果糖) 规格与包装: 每盒30片 推荐的每天用量: 成人每天1片或遵医嘱 婴儿每天1/2片，与牛奶一起服用。 产品说明 很少有人会意识到大多数的细菌还具有重要的作用。 举例来说，一个无菌的大便可能在短期内是致死性的。另一个有关的例子是，在自然界，所有的废(弃)物是通过细菌进行再循环，例如，亚硝酸盐与亚硝酸细菌，这是生态平衡所必需的。 换言之，我们还应记住，绝大部分的细菌是不致病的，而且还是很重要的。在我们肠道内，大约有400株不同的细菌互不干扰地共生在一起。 人们也往往忽略了此一事实，环境与细菌是同样重要的，因为如果没有合适的培养基质，病毒、细菌、霉菌等都无法生长。当你的肠道菌群发生紊乱后，你就得了“微生态失调”症(bysbiosis)。 肠道菌群的重要作用之一是能产生某些酸性物质，它们能抑制某些有害细菌的生长。 1 “益生菌”此一术语是用于指那些对肠道生态环境起到有益作用的菌群。此一术语的命名也是合适的，因为此类细菌属于低植物布居的型式(low plant population)。它包括乳杆菌、比非德氏杆菌 以及其他非乳酸类杆菌，例如用酵母菌基质制备的布拉迪氏酵母菌。 现在，含益生菌的营养补充品已用于肠道紊乱的病人，但迄尚未列入药物这一类别。 据统计，50%在疹所就医的病人，均属于胃肠道疾病的病人(胃酸过多、胃痉挛、便秘、腹泻、胃胀气等等。对于这些疾病，通常仅是对症治疗，有时病人被告知需永久性服药。 为了能持续纠正肠道菌群紊乱，应用肠道菌群中的固有微生物菌是很重要的。如使用属于外来微生物菌，例如酸乳酪中的保加利亚乳酸杆菌和嗜热链球菌，通常仅能短期存活在肠道内，而固有微生物菌则能长期生存，这个区别是很显著的。对正常肠道菌群来说，嗜酸乳杆菌及双叉乳杆菌是相当重要的。大家都知道，使用抗菌素后，肠道菌群可能会发生严重的紊乱。但是一个坏的饮食习惯及精神紧张同样亦会使肠道菌群的生态环境失衡。严重的便秘及腹泻就是此种症象的一个重要信号。已有证据表明，精神紧张会导致肠内细菌的特性发生变化而粘附在肠壁上。 14我们可能还忽略了这一点，肠道内的菌群(大约有2kg或10个共生菌)本身还会具有抗菌的特点。这些菌群能产生大量的酸，形成了不利于病原微生物生长的高酸性环境。某些肠道细菌，除了具有天然抗菌特性而能杀死外来细菌外，还能大量地附在肠壁上，用此种方法阻止危险的外来菌进一步繁殖。 值得注意的是，肠道菌群的功能还不止于抗菌的功能;它们还能在其他方面促进健康。 它们产生的一些酶能帮助消化。一个明显的例子是乳糖酶，如有乳糖不耐症时，该酶就能促进乳糖的消化。 我们还注意到，嗜酸乳杆菌能降低胆固醇的水平。下列的例子说明，我们并不泛指整个的肠道菌群，而是指某些特定的菌株具有某些特定的效应。 笼统地讨论“益生菌”并没有多大的实际意义。有一点很清楚的是，如要达到特定的效果，则应使用效果明确的特定菌株。现有足够的证据表明，嗜酸乳杆菌、鼠李糖乳杆菌及胚芽乳杆菌能加强体内的免疫系统，对腹泻也有效果。对于细菌性阴道疾病，鼠李糖乳杆菌的效果最好。最近有文献报道，孕妇服用乳酸杆菌能降低未来婴儿患湿疹及过敏性疾病的发生率。 现已证实，上述的菌株不会被胃酸、胆汁及胰液所破坏。它们能在胃的酸度环境中存活，而存在于酸乳酪中的益生菌，很难在胃内继续存活。 2 同样的一个既定事实是，能在肠道或阴道内寄生的菌群，其数量的多少也是一个很重要的条件。研究表 明，对乳酸杆菌来说，要在肠内寄生，通常需要的量为10~100亿个。 注意事项: 无特殊的指征 下列的参考文献表明，此产品中的活性物质有助于肠道菌群的平衡 及正常功能的维护。 参考文献 Fuller R, editor. Probiotics: the scientific basis. London: Chapman & Hall; 1992. 1 Fuller R. A review: probiotics in man and animals. J Appl Bacteriol 1989;66:365-78. 2 Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of 3 prebiotics. J Nutr 1995;125:1401-12. Sadler MJ, Saltmarsh M, editors. Functional foods. Cambridge: Royal Society of Chemistry; 1998. pp4-5. 4 Macfarlane GT, Cummings JH. Probiotics and prebiotics: can regulating the activities of intestinal bacteria 5 benefit health? BMJ 1999;318:999-1003. MacGillivray PC, Finlay HVL, Binns TB. Use of lactulose to create a preponderance of lactobacilli in the 6 intestine of bottle-fed infants. Scott Med J 1959;4:182-9. Gibson GR, Beatty EB, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon 7 by oligofructose and inulin. Gastroenterology 1995;108:975-82. Rowland IR, Tanaka R. The effects of transgalactosylated oligosaccharides on gut flora metabolism in rats 8 associated with human faecal microflora. J Appl Bacteriol 1993;74:667-74. Collins MD, Gibson GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial 9 ecology of the gut. Am J Clin Nutr 1999;69:1052S-7S. Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000;130:396S-10 402S. Elmer GW, Surawicz CM, MacFarland LV. Biotherapeutic agents. A neglected modality for the treatment 11 and prevention of selected intestinal and vaginal infections. JAMA 1996;275:870-6. de Roos NM, Katan MB. Effects of probiotic bacteria on diarrhea, lipid metabolism, and carcinogenesis: a 12 review of papers published between 1988 and 1998. Am J Clin Nutr 2000;71:405-11. Oksanen PJ, Salminen S, Saxelin M, Hamalainen P, Ihantola-Vormisto A, Muurasniemi-Isoviita L, et al. 13 Prevention of travellers’ diarrhoea by Lactobacillus GG. Ann Med 1990;22:53-6. Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in 14 travellers. J Travel Med 1997;4:41-3. Black FT, Andersen PL, Orskov J, Orskov F, Gaarslev K, Laulund S. Prophylactic efficacy of lactobacilli on 15 travellers’ diarrhoea. In: Steffen R, editor. Travel medicine. Conference on international travel medicine 1, Zurich, Switzerland. Berlin: Springer; 1989. pp333-5. Kollaritsch H, Wiedermann G. Travellers’ diarrhoea among Austrian tourists: epidemiology, clinical features 16 and attempts at non-antibiotic drug prophylaxis. In: Pasini W, editor. Proceedings of the second international conference on tourist health. Rimini: World Health Organisation; 1990. pp74-82. Katelaris PH, Salam I, Farthing MJG. Lactobacilli to prevent travellers’ diarrhea? N Engl J Med 17 1995;333:1360-1. Siitonen S, Vapaatalo H, Salminen S, Gordin A, Saxelin M, Wickberg R, et al. Effect of Lactobacillus GG 18 yoghurt in prevention of antibiotic associated diarrhoea. Ann Med 1990;22:57-9. Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with 19 Lactobacillus GG (letter). Lancet 1987;2:1519. Wunderlich PF, Braun L, Fumagalli I, D’Apuzzo V, Heim F, Karly M, et al. Double-blind report on the 20 efficacy of lactic acid producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea in the treatment of acute diarrhoea. J Int Med Res 1989;17:333-8. Tankanow RM, Ross MB, Ertel IJ, Dickinson DG, McCormick LS, Garfinkel JF. A double-blind, placebo-21 controlled study of the efficacy of Lactinex in the prophylaxis of amoxicillin-induced diarrhoea. Ann 3 Pharmacol 1990;24:382-4. Black F, Einarsson K, Lidbeck A, Orrhage K, Nord CE. Effect of lactic acid producing bacteria on the 22 human intestinal microflora during ampicillin treatment. Scand J Infect Dis 1991;23:247-54. Sanders ME. Summary of the conclusions from a consensus panel of experts on health attributes on lactic 23 cultures: significance to fluid milk products containing cultures. J Dairy Sci 1993;76:1819-28. Mustapha A, Jiang T, Savaino DA. Improvement of lactose digestion by humans following ingestion of 24 unfermented acidophilus milk: influence of bile sensitivity, lactose transport, and acid tolerance of Lactobacilllus acidophilus. J Dairy Sci 1997;80:1537-45. Saltzman JR, Russell RM, Golner B, Barakat S, Dallal GE, Goldin BR. A randomized trial of Lactobacillus 25 acidophilus BG2F04 to treat lactose intolerance. Am J Clin Nutr 1999;69:140-6. Shalev E, Battino S, Weiner E, Colodner R, Keness Y. Ingestion of yoghurt containing Lactobacillus 26 acidophilus compared with pasteurized yoghurt as prophylaxis for recurrent candidal vaginitis and bacterial vaginosis. Arch Fam Med 1996;5:593-6. De Simone C, Ciardi A, Grassi A, Lambert Gardinin S, Tzantzoglou S, Trinchieri V. Effect of 27 Bifidobacterium bifidum and Lactobacillus acidophilus on gut mucosa and peripheral blood B lymphocytes. Immunopharmacol Immunotoxicol 1992;14:331-40. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A. Immunomodulation of human 28 blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 1995;78:491-7. Majaama M, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin 29 Immunol 1997;99:179-85. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. 30 Clin Exp Allergy 2000;30:1605-10. Jackson TG, Taylor GRJ, Clohessy AM, Williams CM. The effects of the daily intake of inulin on fasting 31 lipid, insulin and glucose concentrations in middle-aged men and women. Br J Nutr 1999;89:23-30. Anderson JW, Gillialand SE. Effect of fermented milk (yogurt) containing Lactobacillus acidophilus L1 on 32 serum cholesterol by hypercholesterolemic humans. J Am Coll Nutr 1999;18:43-50. Schaafsma G, Meuling WJ, van Dokkum W, Bouley C. Effects of a milk product, fermented by 33 Lactobacillus acidophilus and with fructo-oligosaccharides added, on blood lipids in male volunteers. Eur J Clin Nutr 1998;52:436-40. Davidson MH, Maki KC, Synecki C. Evaluation of the influence of dietary inulin on serum lipids in adults 34 with hypercholesterolemia. Nutrition 1998;18:503-17. Mital BK, Garg SK. Anticarcinogenic, hypocholesterolemic and antagonistic activities of Lactobacillus 35 acidophilus. Crit Rev Microbiol 1995;21:175-214. Reddy BS, Rivenson A. Inhibitory effect of Bifidobacterium longum on colon, mammary and liver 36 carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Cancer Res 1993;53:3914-8. Taper HS, Delzenne NM, Roberfroid MB. Growth inhibition of transplantable mouse tumours by 37 nondigestible carbohydrates. Int J Cancer 1997;71:1109-12. Aso Y, Akazan H, BLP Study Group. Prophylactic effect of a Lactobacillus casei preparation on the 38 recurrence of superficial bladder cancer. Urol Int 1992;49:125-9. Coudray C, Bellanger J, Catiglia-Delavaud C, Remesy C, Vermorel M, Rayssignuier Y. Effect of soluble 39 and partly soluble dietary fibres supplementation on absorption and balance of calcium, magnesium, iron and zinc in healthy young men. Eur J Clin Nutr 1997;51:375-80. van den Heuvel EGHM, Muys T, van Dokkum W, Schaafsma G. Oligofructose stimulates calcium 40 absorption in adolescents. Am J Clin Nutr 1999;69:544-8. Canganella F, Paganini S, Ovidi M, Vettraino AM, Bevilacqua L, Massa S, et al. A microbiology 41 investigation on probiotic pharmaceutical products used for human health. Microbiol Res 1997;152:171-9. ÿ Nutriphyt – - info@nutriphyt.be 本产品的说明由营养学专家所撰写，是专供从事于保健食品的专业人士阅读的。非专业人员与用户不是此文的阅读对象。作出诊 断及推荐合适的疗法属于保健专家的责职。 4